Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Amor B, Silva Santos R, Nahal R, Listrat V, Dougados M (1994) Predictive factors for the long term outcome of spondyloarthropathies. J Rheumatol 21:1883–1887
Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedzic K, Dawes PT (1996) Smoking and outcome in ankylosing spondylitis. Scand J Rheumatol 25:138–142
Boers M (1994) Predicting outcome of ankylosing spondylitis: prognosis or hindsight? J Rheumatol 21:1789–1790
Boonen A, Chorus A, Miedema H, van der Heijde D, van der Tempel H, van der Linden S (2001a) Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients. Ann Rheum Dis 60:353–358
Boonen A, Chorus A, Miedema H, van der Heijde D, Landewe R, Schouten H, van der Tempel H, van der Linden S (2001b) Withdrawal from labour force due to work disability in patients with ankylosing spondylitis. Ann Rheum Dis 60:1033–1039
Boonen A, van der Heijde D, Landewe R, Spoorenberg A, Schouten H, Rutten van Mölken M, Guillemin F, Dougados M, Mielants H, de Vlam K, van der Tempel H, van der Linden S (2002) Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis 61:429–437
Boonen A, van der Heijde D, Landewé R, Guillemin F, Rutten-van Mölken M, Dougados M, Mielants H, de Vlam K, van der Tempel H, Boesen S, Spoorenberg A, Schouten H (2003) Direct costs of ankylosing spondylitis and its determinants. An analysis among three European countries. Ann Rheum Dis 62:732–740
Braun J, Sieper J (2004) Biological therapies in the spondyloarthritides — the current state. Rheumatology (Oxford) [Epub ahead of print]
Brophy S, Mackay K, Al-Saidi A, Taylor G, Calin A (2002) The natural history of ankylosing spondylitis as defined by radiological progression. 29:1236–1243
Brophy S, Calin A (2001) Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J Rheumatol 28:2283–2288
Calin A, Elswood J, Rigg S, Skevington SM (1988) Ankylosing spondylitis — an analytical review of 1500 patients: the changing pattern of disease. J Rheumatol 15:1234–1238
Calin A, Elswood J (1989) The outcome of 138 total hip replacements and 12 revisions in ankylosing spondylitis: High success rate after a mean followup of 7.5 years. J Rheumatol 16:955–958
Calin A, Kennedy LG, Edmunds L, Will R (1993) Familial versus sporadic ankylosing spondylitis — two different diseases? Arthritis Rheum 36:676–681
Carbone LD, Cooper C, Michet CJ, Atkinson EJ, O’Fallow Wm, Melton LJ 3rd (1992) Ankylosing spondylitis in Rochester, Minnesota, 1935–1989. Is the epidemiology changing? Arthritis Rheum 35:1476–1482
Chorus AMJ, Boonen A, Miedema HS, van der Linden S (2002) Employment perspectives of patients with ankylosing spondylitis. Ann Rheum Dis 61:693–699
Doward LC, Spoorenberg A, Cook SA, et al (2003) Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 62:20–26
Falkenbach A, Franke A, van der Linden S (2003) Factors associated with body function and disability in patients with ankylosing spondylitis: a cross-sectional study. J Rheumatol 30:2186–2192
Falkenbach A, Griessmayer H, Tripathi R (1998) Effect of a positive family history on the prognosis in patients with Bechterew disease. Wien Klin Wochenschr 110:20–22
Falkenbach A, Tripathi R, Griessmayer H (1997) Primary ankylosing spondylitis: is it important to sleep flat? (Abstrakt) Br J Rheumatol 36,Suppl.1:129
Feldtkeller E, Lemmel E-M (1999) Zur Situation von Spondyloarthritis-Patienten. Novartis Pharma pp 61–76
Fries JF, Singh G, Bloch DA, Calin A (1989) The natural history of ankylosing spondylitis: is the disease really changing? J Rheumatol 16:860–863
Gran JT, Husby G, Hordvik M, Stormer J, Romberg-Anderen O (1984) Radiological changes in men and women with ankylosing spondylitis. Ann Rheum Dis 43:570–575
Gran JT, Ostensen M, Husby G (1985) A clinical comparison between males and females with ankylosing spondylitis. Br J Rheumatol 12:126129
Gran JT, Skomsvoll JF (1997) The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 36:766–771
Guillemin F, Briancon S, Pourel J, Gaucher A (1990) Longterm disability and prolonged sick leaves as outcome measurements in ankylosing spondylitis. Possible predictive factors. Arthritis Rheum 33:1001–1006
Hamersma J, Cardon LR, Bradbury L, Brophy S, van der Horst-Bruinsma I, Calin A Brown MA (2001) Is disease severity in ankylosing spondylitis genetically determined? ArthritisRheum 44:1396–1400
Huscher D, Thiele K, Merkesdal S, Zeidler H, Zink A (2002) Comparison of the annual direct and indirect costs in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. Arthritis Rheum 46(Abstract):S93
Khan MA, Khan MK, Kushner I (1981) Survival among patients with ankylosing spondylitis: a life-table analysis. J Rheumatol 8:86–90
Kennedy LG, Edmund L, Calin A (1993) The natural history of ankylosing spondylitis: does it burn out? J Rheumatol 20:688–692
Kidd B, Mullee M, Frank A, Cawley M (1988) Disease expression of ankylosing spondylitis in males and females. J Rheumatol 15:1407–1409
Lehtinen K (1993) Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 52:174–176
Little H (1988) The natural history of ankylosing spondylitis. J Rheumatol 15:1179–1180
Mau W, Zeidler H, Mau R, Majewski A, Freyschmidt J, Stangel W, Deicher H (1988) Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup. J Rheumatol 15:1109–1114
Mau W, Zeidler H, Mau R, Majewski A, Freyschmidt J, Deicher H (1987) Outcome of possible ankylosing spondylitis in a 10-year follow-up study. Clin Rheumatol 6(Suppl 2) 60–66
Radford EP, Doll R, Smith PG (1977) Mortality among patients with ankylosing spondylitis not given X-ray therapy. N Engl J Med 297:572–576
van der Linden SM, Valkenburg HA, de Jong BM, Cats A (1984) The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 27:241–249
van der Paardt M, Dijkmans B, Giltay E, van de Horst-Bruinsma I (2002) Dutch patients with familial and sporadic ankylosing spondylitis do not differ in disease phenotype. J Rheumatol 29:2583–2584
van Tubergen A, Landewé R, van der Heijde D, et al (2001) Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum 45:430–438
van Tubergen A, Boonen A, Landewé R, et al (2002) Cost-effectiveness of combined spaexercise therapy in ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum 47:459–467.
Ward MM (1999) Health-related quality of life in ankylosing spondylitis: a survey of 175 patients. Arthritis Care Res 12:247–255
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag/Wien
About this chapter
Cite this chapter
van der Linden, S., Falkenbach, A. (2005). Prognose. In: Felkenbach, A. (eds) Morbus Bechterew. Springer, Vienna. https://doi.org/10.1007/3-211-26646-1_5
Download citation
DOI: https://doi.org/10.1007/3-211-26646-1_5
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-00808-9
Online ISBN: 978-3-211-26646-5
eBook Packages: Medicine (German Language)